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pTATE-OF-THE-ART PAPER2231Cardiotoxicity of Cancer Therapydward T. H. Yeh, Courtney L. Bickford
any of the life-prolonging therapies currently used for cancer patients can cause
ardiovascular complications such as heart failure, myocardial ischemia/infarction,
ypertension, thromboembolism, and arrhythmias. In this paper, Yeh and Bickford review the
ncidence of cardiotoxicity caused by commonly used chemotherapeutic agents as well as
iscuss the pathogenesis, diagnosis, management, and prevention of these cardiovascular side
ffects. This paper will likely serve as an important reference article for both cardiologists and
ncologists.TATE-OF-THE-ART PAPER2248End Points for Clinical Trials in AHFSarry A. Allen, Adrian F. Hernandez, Christopher M. O’Connor, G. Michael Felker
llen and colleagues review the literature regarding treatments for acute heart failure
yndromes (AHFS). Some agents have shown benefit on short-term hemodynamics, but
ppear to increase mortality or have at best minimal long-term efficacy. The utility of various
nd points, ranging from clinical end points from mortality to dyspnea and surrogate end
oints including biomarkers are reviewed. Greater standardization of end points is needed for
he various therapies to be easily compared and prioritized by clinicians and payers.NEWS FROM THE NHLBI EWS FROM THE NHLBI2259How One Program at NHLBI Establishes its Scientific Prioritiesiane E. Bild, Michael S. Lauer
ne of the major roles of NHLBI program staff is to establish, implement, and evaluate
pecific priorities identified by the NHLBI Strategic Plan. In this paper, Bild and Lauer
xplore the methods used by the Population Sciences Program (PSP) for extramural
ardiovascular research to establish research priorities for the larger grants that require pre-
eview. The most important factor identified was “impact on population health.” The next 4
ost important factors were “feasibility,” “relevance to the PSP mission,” the “need for or
revious lack of studies on this topic,” and “quality of the proposed methods.”(continued on page A-25)
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hLINICAL TRIALS2262Sustained Benefits From Post-MI Bone Marrow Cell InjectionEditorial Comment
James S. Forrester, Raj R. Makkar,uhammad Yousef, Christiana Mira Schannwell, Mathias Köstering, Tobias Zeus, Michael Brehm,
odo Eckehard Strauer
ousef and colleagues report 5-year outcomes from 62 patients who underwent intracoronary
utologous bone marrow cell (BMC) injection approximately 1 week after suffering an
nterior myocardial infarction (MI). Compared to a matched contemporaneous cohort, there
ere significant improvements in ejection fraction (EF), stroke volume index, and infarct size
t 3 months. Improvements in contractility, hemodynamics, and geometry were maintained
ver 5 years, and there was a statistically significant mortality reduction with BMC. In this
tudy, BMC therapy led to significant and longstanding improvements of both left ventricular
erformance and mortality.ARDIOVASCULAR RISK2273Aortic IMT May Be Superior to Carotid IMT in AdolescentsEditorial Commenteffrey D. Dawson, Milan Sonka, Mary Beth Blecha, Wenjiao Lin, Patricia H. Davis
atty streaks in the abdominal aorta are known to develop in children, especially those with
ardiovascular risk factors. Dawson and colleagues studied a group of children with ultrasound
easurements of intima-media thickness (IMT) from both the carotids and the distal aorta.
oth aortic intima-media thickness (aIMT) and carotid intima-media thickness (cIMT) were
ound to be associated with several cardiovascular risk factors, suggesting that both methods
ay be useful; however, in adolescents, several risk factors had significantly stronger
ssociations with aIMT than with cIMT. Both aIMT and cIMT are associated with
ardiovascular risk factors, but aIMT may be superior in adolescents.IET AND ENDOTHELIAL FUNCTION2283High Glycemic Index Foods Inhibit Flow-Mediated Dilationalya Lavi, Avraham Karasik, Nira Koren-Morag, Hannah Kanety, Micha S. Feinberg, Michael Shechter
avi and colleagues assessed brachial artery flow-mediated dilation (FMD) in nondiabetic
olunteers on 4 separate mornings, before and after the consumption of food of varying
lycemic indexes. The meals ranged from glucose to cornflakes, fiber cereal, and placebo in
eclining order of glycemic index. Fasting and 2-h post-prandial serum glucose levels were
imilar for all 3 meals, but were higher at 30 to 90 min for the high-glycemic meals. FMD
as reduced 2 h post-prandial in all groups, but there was a more marked reduction after the
igh-glycemic meals. Meals with a high-glycemic index appear to impair endothelial function.(continued on page A-26)
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SONGENITAL HEART DISEASE2288Aortopathy Is Prevalent in Relatives of Bicuspid Aortic Valve PatientsEditorial Commentimon Biner, Asim M. Rafique, Indraneil Ray, Olivera Cuk, Robert J. Siegel, Kirsten Tolstrup
irst-degree relatives (FDRs) of patients with bicuspid aortic valve (BAV) are at an increased
isk of inheriting BAV and other cardiovascular malformations, possibly including aortic root
orphologic and functional abnormalities. Biner and colleagues prospectively performed
chocardiograms on FDRs of BAV patients. The prevalence of aortic root dilation was 32%
n FDRs and 53% in BAV patients, whereas all controls had normal aortic dimensions.
DRs and BAVs had significantly lower aortic distensibility and greater aortic stiffness
ompared with controls. FDRs of patients with BAV are more likely to have enlarged and
tiff aortic roots.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH
2298gents in Drug-Eluting Stents Induce Senescence in Endothelial Cells
Through Sirt1idetaka Ota, Masato Eto, Junya Ako, Sumito Ogawa, Katsuya Iijima, Masahiro Akishita, Yasuyoshi Ouchi
ecently, Ota and colleagues reported that cilostazol inhibited oxidative stress-induced
ndothelial senescence through up-regulation of Sirt1. For this study, cultured human
mbilical vein endothelial cells were exposed to paclitaxel, sirolimus, and everolimus and were
ound to cause changes in cell morphology and reduced cell reproduction associated with a
ecrease in Sirt1 expression. Overexpression of Sirt1 or cotreatment with cilostazol reversed
he sirolimus- or everolimus-induced senescent phenotype, but not the changes with
paclitaxel. Sirolimus and everolimus induce endothelial senescence via down-regulation of
irt1; cilostazol appears to prevent this.
